Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patients.
Saved in:
| Title: | Common connective tissue disorder and anti-cytokine autoantibodies are enriched in idiopathic multicentric castleman disease patients. |
|---|---|
| Authors: | Feng A; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, United States.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, United States., Gonzalez MV; Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Philadelphia, PA, United States., Kalaycioglu M; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, United States.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, United States., Yin X; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, United States.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, United States., Mumau M; Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Philadelphia, PA, United States., Shyamsundar S; Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Philadelphia, PA, United States., Bustamante MS; Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Philadelphia, PA, United States., Chang SE; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, United States.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, United States., Dhingra S; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, United States.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, United States., Dodig-Crnkovic T; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden., Schwenk JM; Science for Life Laboratory, Department of Protein Science, KTH Royal Institute of Technology, Stockholm, Sweden., Garg T; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, United States., Yoshizaki K; Department of Biomolecular Science and Regulation, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan., van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, United States., Fajgenbaum DC; Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Philadelphia, PA, United States., Utz PJ; Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, United States.; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Mar 13; Vol. 16, pp. 1528465. Date of Electronic Publication: 2025 Mar 13 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1528465 |
